CORDIS
EU research results

CORDIS
English EN

Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds

Project information

Grant agreement ID: 825489

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2023

Funded under:

H2020-EU.3.1.1.

  • Overall budget:

    € 6 761 833,75

  • EU contribution

    € 6 761 833,75

Coordinated by:

UNIVERSITEIT UTRECHT

Netherlands

Objective

GOLIATH addresses the work programme topic ‘SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals (EDCs)’ by focussing on one of the most urgent regulatory needs, namely the lack of methods for testing EDCs that disrupt metabolism – chemicals collectively referred to as ‘metabolism disrupting chemicals’ (MDCs). MDCs are natural and anthropogenic chemicals that have the ability to promote metabolic changes that can ultimately result in obesity, diabetes and/or fatty liver in humans. GOLIATH will generate the world’s first integrated approach to testing and assessment (IATA) specifically tailored to MDCs. With a focus on the main cellular targets of metabolic disruption – hepatocytes, pancreatic endocrine cells, myocytes and adipocytes - GOLIATH will develop new methods and optimise existing methods that span the entire adverse outcome pathway (AOP) spectrum, using in silico predictive modelling and high throughput screening, (pre-)validated ready-to-use in vitro assays and optimised in vivo toxicity testing guidelines. GOLIATH will provide key information on the endocrine mode of action by which MDCs disrupt metabolic pathways and induce adverse effects on human health by incorporating multi-omics technologies, and translating results from in vitro and in vivo assays to adverse metabolic health outcomes in humans at real life exposures. Given the importance of international acceptance of the developed test methods for regulatory use, GOLIATH will link with ongoing initiatives of the OECD for test method (pre-)validation, IATA and AOP development. With a consortium comprised of world-leading experts in endocrinology, molecular biology, toxicology, epidemiology, test method development, validation and chemical regulation, GOLIATH will be pivotal in the development of an internationally harmonised strategy for testing MDCs, and help to reduce the worldwide rise in metabolic disorders that have reached ‘Goliathan’ proportions.

Field of Science

/medical and health sciences/clinical medicine/endocrinology

/medical and health sciences/health sciences/epidemiology

/natural sciences/biological sciences/molecular biology

/medical and health sciences/basic medicine/toxicology

/medical and health sciences/clinical medicine/endocrinology/diabetes

Programme(s)

H2020-EU.3.1.1. - Understanding health, wellbeing and disease

Topic(s)

SC1-BHC-27-2018 - New testing and screening methods to identify endocrine disrupting chemicals

Call for proposal

H2020-SC1-2018-Single-Stage-RTD

See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

UNIVERSITEIT UTRECHT

Address

Heidelberglaan 8
3584 Cs Utrecht

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 268 269,88

Website

Contact the organisation

Participants (14)

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT

France

EU Contribution

€ 798 786,25

Department of Health

United Kingdom

EU Contribution

€ 459 104,53

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 1 077 695

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 402 500

UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Spain

EU Contribution

€ 672 862,50

AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L ALIMENTATION DE L ENVIRONNEMENT ET DU TRAVAIL

France

EU Contribution

€ 134 250

LINKOPINGS UNIVERSITET

Sweden

EU Contribution

€ 338 287,50

VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.

Belgium

EU Contribution

€ 137 510

BRUNEL UNIVERSITY LONDON

United Kingdom

EU Contribution

€ 261 946,25

THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

EU Contribution

€ 248 525

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

United States

EU Contribution

€ 339 596,84

BIOPREDIC INTERNATIONAL SARL

France

EU Contribution

€ 243 750

HOFFMANN SEBASTIAN

Germany

EU Contribution

€ 75 000

UMEA UNIVERSITET

Sweden

EU Contribution

€ 303 750

Project information

Grant agreement ID: 825489

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2023

Funded under:

H2020-EU.3.1.1.

  • Overall budget:

    € 6 761 833,75

  • EU contribution

    € 6 761 833,75

Coordinated by:

UNIVERSITEIT UTRECHT

Netherlands

Download

PDF XML

Last update: 13 January 2020

Record number: 220947